Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.
about
High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanomaApoptosis through Bcl-2/Bax and cleaved caspase up-regulation in melanoma treated by boron neutron capture therapyCurrent breast cancer proliferative markers correlate variably based on decoupled duration of cell cycle phases.Immunohistochemical quantification of the vitamin B12 transport protein (TCII), cell surface receptor (TCII-R) and Ki-67 in human tumor xenografts.Phase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette-Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous MelanomaDiagnostic and prognostic biomarkers in melanoma.The curcumin analog DM-1 induces apoptotic cell death in melanoma.Increased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma.Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas--an immunohistochemical studyA high proliferative index of recurrent melanoma is associated with worse survivalBetter see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study.A murine model for the development of melanocytic nevi and their progression to melanoma.H3K79me3T80ph is a Novel Histone Dual Modification and a Mitotic Indicator in Melanoma.Accuracy of in vivo multimodal optical imaging for detection of oral neoplasia.Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An UpdateAutomated quantification of proliferation with automated hot-spot selection in phosphohistone H3/MART1 dual-stained stage I/II melanoma.Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysis.Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.Construction and analysis of multiparameter prognostic models for melanoma outcomePrognostic tissue markers in melanoma.Tissue prognostic biomarkers in primary cutaneous melanoma.Genetically altered fields in head and neck cancer and second field tumor.An evaluation of 2-deoxy-2-[18F]fluoro-D-glucose and 3'-deoxy-3'-[18F]-fluorothymidine uptake in human tumor xenograft models.MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmi1, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesionsPresence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanomaProliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma.Expression of Glut-1 in Malignant Melanoma and Melanocytic Nevi: an Immunohistochemical Study of 400 Cases.Prognostic significance of phospho-histone H3 in prostate carcinoma.Phosphohistone-H3 Proliferation Index Is Superior to Mitotic Index and MIB-1 Expression as a Predictor of Recurrence in Human Meningiomas.Ultrasound-Mediated Microbubble Destruction Suppresses Melanoma Tumor Growth.The relationship between mitotic rate and depth of invasion in biopsies of malignant melanoma.Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma.Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma.Expression analysis of ovostatin 2 reveals its involvement in proliferation, invasion and angiogenesis of cutaneous malignant melanoma.
P2860
Q27498879-10C019FF-21A3-45CD-B527-A6C71DEA2994Q28488368-97CE965A-719E-4D74-914B-A253501D63D9Q33687123-389442E9-9403-4C35-864A-0E665C9C8885Q33702468-B4B067D1-2B4D-411B-9413-820498A0ED9DQ33741471-8FA0468C-E4F2-469A-BC02-5ABC12E06887Q33862470-5F8DBF80-77DB-4081-8385-A039F3088130Q34566244-4F64D084-861A-475B-B338-B989B3BE92BCQ34717034-F69C208E-32A3-499F-84C6-FA3C1A496DE7Q35081279-B7CD2A4B-502E-4AEA-81B4-41970F3BDFD2Q35089965-BA115E79-DB8F-4FE7-9875-1C7F087C1CDAQ35788622-43BB4DFA-499C-46BE-BE05-1871CB1736A7Q36014062-F2970A59-8C8A-4A41-B1AB-FA492CB1B8A3Q36073207-08989E68-63C2-41F9-8762-9D502701FC3AQ36440275-C5AA0BF3-473C-476F-A7A4-2EF9B981EE4DQ36578066-92ECA99F-1DC9-4C8D-8B05-5244C4BB064BQ36752423-4B09D839-A0BA-46DA-8D90-C75084345A65Q36783370-BEB79629-09B5-4162-B6FB-8603DBB96FD9Q36844251-FBE511E5-0918-4EC3-8155-EFC28C1BBB25Q37478823-CDB76DBF-03A7-4ED8-A5F4-F9DF6A495CCCQ37550749-224DCE07-0D1F-473D-A105-BB27F3B1DDD3Q37924320-3D4B6DD4-33E2-4DA7-8984-CEF3693A4C76Q38184377-51587C02-0414-485E-97BD-453A26B9E4A4Q38241211-0E6D1689-9F4F-439D-A1BC-B1CDAC7DCAE6Q39506288-97223694-D601-4D71-BD0E-76A5CC251B0EQ40523473-20B83CBC-7E3A-4269-957D-7CBC01EC8969Q41558364-F0C16F26-95C5-4278-B4EA-348AAC179F80Q46928169-F4BE7C63-1D57-4B8A-B56B-EA108A900882Q47612204-B3E46711-449D-4B5F-8B30-B87387AC9CFCQ47931762-B1838E8E-27C5-4E19-9DA6-C2BDA37F893EQ51448302-93FFF8C9-41C1-4827-91DB-B2D9CA5AED62Q52707633-E78DCAB7-0D9F-41C0-938A-E7D1620F1BC9Q52723668-B1CE8CEB-CFC1-4BB9-91F5-D9A0FB0D22BCQ53072433-D42E806F-A080-4B93-B88A-316716498986Q53112985-E6A90F83-B70C-49FD-B074-C2D02BE26844Q54240232-AB9C86B8-FDEE-44F7-8C00-669CC92718C9
P2860
Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Ki-67 expression is superior t ...... r in thick cutaneous melanoma.
@ast
Ki-67 expression is superior t ...... r in thick cutaneous melanoma.
@en
Ki-67 expression is superior t ...... r in thick cutaneous melanoma.
@nl
type
label
Ki-67 expression is superior t ...... r in thick cutaneous melanoma.
@ast
Ki-67 expression is superior t ...... r in thick cutaneous melanoma.
@en
Ki-67 expression is superior t ...... r in thick cutaneous melanoma.
@nl
prefLabel
Ki-67 expression is superior t ...... r in thick cutaneous melanoma.
@ast
Ki-67 expression is superior t ...... r in thick cutaneous melanoma.
@en
Ki-67 expression is superior t ...... r in thick cutaneous melanoma.
@nl
P2860
P356
P1433
P1476
Ki-67 expression is superior t ...... r in thick cutaneous melanoma.
@en
P2093
Ingeborg M Bachmann
Rita G Ladstein
P2860
P2888
P356
10.1186/1471-2407-10-140
P407
P577
2010-04-14T00:00:00Z
P5875
P6179
1047397560